Filing Details
- Accession Number:
- 0001209191-20-020922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-24 16:14:31
- Reporting Period:
- 2020-03-20
- Accepted Time:
- 2020-03-24 16:14:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
718937 | Staar Surgical Co | STAA | Ophthalmic Goods (3851) | 953797439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1496615 | J Samuel Gesten | 25651 Atlantic Ocean Drive Lake Forest CA 92630 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-20 | 7,745 | $0.00 | 42,873 | No | 4 | A | Direct | |
Common Stock | Disposition | 2020-03-23 | 2,742 | $27.42 | 41,185 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options | Acquisiton | 2020-03-20 | 16,102 | $0.00 | 16,102 | $27.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,102 | 2021-03-20 | 2030-03-19 | No | 4 | A | Direct |
Footnotes
- Award of 7745 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23.
- The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.